NeGIO Therapeutics

Ottignies-Louvain-la-Neuve ·KBO/BCE: BE 0799.822.012

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	26-05-2026	66 d early	2026-00120028
31-12-2024	31-07-2025	30-07-2025	1 d early	2025-00328382
31-12-2023	31-07-2024	28-08-2024	28 d late	2024-00427060

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€4.76M
Fixed assets	21/28	€4k
Tangible fixed assets	22/27	€4k
Current assets	29/58	€4.76M
Amounts receivable within one year	40/41	€389k
Cash & bank	54/58	€4.37M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€4.76M
Equity	10/15	€4.75M
Contributions / capital	10/11	€10.08M
Accumulated profits (losses)	14	€-5.33M
Amounts payable	17/49	€12k
Amounts payable within one year	42/48	€12k
Trade debts payable within one year	44	€12k
Income statement
Gross operating margin	9900	€-196k
Operating result	9901	€-672k
Financial income	75	€67k
Financial charges	65	€3k
Result before taxes	9903	€-608k
Income taxes	67/77	€182
Net result for the period	9904	€-608k
Result to be appropriated	9905	€-608k

NACE primary	Vervaardiging van farmaceutische grondstoffen(21100)
Legal form	Public limited company(014)
Incorporation	22-03-2023
Status	Active
Postal code	1348

Summary

Parcel (capakey)	Region	Area	Buildings	Height / fl.
25386B0152/00N000	Wallonia	4.0 ha	1 · 1.2 ha	34.9 m · 2 fl.
21018B0068/00C000	Brussels	3,511 m²	1 · 939 m²	38.0 m · 10 fl.